Medtronic plc (MDT)
NYSE
Closed
Aug 25, 2026
Day's Range
91.1152 wk Range
73.31Overview - MDT - Medtronic plc
Key Statistics
Valuation
Enterprise Value
140.03B
P/E (Trailing)
‪25.02‬
P/E (Forward)
‪14.56‬
PEG Ratio
‪1.36‬
Price / Sales (TTM)
‪3.28‬
Price / Book
‪2.41‬
EV / EBITDA
‪13.86‬
Profitability
Gross Margin
‪65.35%‬
Profit Margin
‪13.20%‬
Operating Margin
‪22.04%‬
Return on Assets
‪4.91%‬
Return on Equity
‪9.84%‬
Ownership
Shares Outstanding
1.28B
Float
1.27B
Short % of Shares Outstanding
‪1.41%‬
Held by Insiders
‪0.39%‬
Held by Institutions
‪88.79%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪84.35‬
200-Day Avg
‪89.80‬
Dividends
Payout Ratio
‪76.14%‬
Frequency
Quarterly
Analyst Consensus
29 analysts
Average price target
‪$ 98.44‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MDT - Medtronic plc
Peers - MDT - Medtronic plc
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
- MDTNYSEMedtronic plc118.91BMarket Cap+0.93%52-week change25.03P/E (Trailing)‪13.20%‬Profit Margin
- CVXNYSEChevron Corporation398.38BMarket Cap+21.55%52-week change19.34P/E (Trailing)‪9.83%‬Profit Margin
- ABTNYSEAbbott Laboratories201.88BMarket Cap-13.28%52-week change37.75P/E (Trailing)‪11.64%‬Profit Margin
- SYKNYSEStryker Corporation126.81BMarket Cap-19.27%52-week change34.15P/E (Trailing)‪14.43%‬Profit Margin
- ICENYSEIntercontinental Exchange, Inc.90.52BMarket Cap-11.10%52-week change22.71P/E (Trailing)‪38.24%‬Profit Margin
- BSXNYSEBoston Scientific Corporation71.02BMarket Cap-114.47%52-week change20.39P/E (Trailing)‪17.49%‬Profit Margin
- EWNYSEEdwards Lifesciences Corporation51.75BMarket Cap+9.95%52-week change53.45P/E (Trailing)‪15.43%‬Profit Margin
Profile Summary - MDT - Medtronic plc
About
Medtronic plc is a global leader in medical technology, developing and manufacturing devices and therapies that address over 70 health conditions. The company operates across four main portfolios: Cardiovascular, which includes cardiac ablation solutions, rhythm management, surgery, coronary and renal denervation,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
